NCT01537497 - A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

PF-05175157

One single oral dose of PF-05175157 will be administered as a powder-in-capsule in the fasting state in the AM.

DRUG

PF-05175157

One single oral dose of PF-05175157 will be administered as a powder-in-capsule in the fasting state in the AM.

DRUG

PF-05175157

One single oral dose of PF-05175157 will be administered as a powder-in-capsule in the fasting state in the AM.

DRUG

Placebo

One single oral dose of placebo will be administered as a powder-in-capsule in the fasting state in the AM.

Trial Locations (1)

Pfizer Investigational Site, South Miami